title: Improving on effective antiretroviral therapy: how good will a cure have to be?
authors.affiliation: Medical Practice Evaluation Center and Divisions of General Internal Medicine and Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.|Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Freedberg
authors.affiliation: Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: Paul E
authors.initials: PE
authors.lastname: Sax
mesh_terms: D016915:AIDS Vaccines; D023241:Antiretroviral Therapy, Highly Active; D035843:Biomedical Research; D003362:Cost-Benefit Analysis; D060740:Disease Eradication / Q000191:economics / Q000379:methods*; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D010330:Patents as Topic
chemical_list: D016915:AIDS Vaccines
keywords: HIV Infection and AIDS